BioHarvest Sciences (FRA:8MV0) E10: €-1.12 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8MV0 BioHarvest Sciences Inc FRA:8MV0
63 GF Score
Price €2.20
GF Value €6.88
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BioHarvest Sciences E10?

BioHarvest Sciences FRA:8MV0 -4.35% 63 E10 is €-1.12 as of Mar. 2026. GuruFocus rates FRA:8MV0 with a GF Score™ of 63/100 and a GF Value™ of €6.88 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioHarvest Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.095. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.12 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-21), BioHarvest Sciences's current stock price is €2.20. BioHarvest Sciences's E10 for the quarter that ended in Mar. 2026 was €-1.12. BioHarvest Sciences's Shiller PE Ratio of today is .


BioHarvest Sciences  (FRA:8MV0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioHarvest Sciences E10 Related Terms


BioHarvest Sciences E10 Historical Data

* Premium members only.

The historical data trend for BioHarvest Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences E10 Chart

BioHarvest Sciences Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.22 -1.11

BioHarvest Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.28 -1.16 -1.24 -1.11 -1.12

FRA:8MV0 vs BRID, BOF, BFNH: E10 Comparison

For the Packaged Foods subindustry, BioHarvest Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioHarvest Sciences Shiller PE Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioHarvest Sciences's Shiller PE Ratio falls into.


FRA:8MV0
63GF Score
BioHarvest Sciences Inc FRA:8MV0
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioHarvest Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioHarvest Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.095/132.2623*132.2623
=-0.095

Current CPI (Mar. 2026) = 132.2623.

BioHarvest Sciences Quarterly Data

per share eps CPI Adj_EPS
201604 -0.271 101.370 -0.354
201607 -0.050 101.844 -0.065
201610 -0.059 102.002 -0.077
201701 -0.040 102.318 -0.052
201704 0.010 103.029 0.013
201707 -0.063 103.029 -0.081
201710 -0.075 103.424 -0.096
201801 -0.037 104.056 -0.047
201804 0.009 105.320 0.011
201807 -0.030 106.110 -0.037
201810 -3.692 105.952 -4.609
201901 -0.613 105.557 -0.768
201904 0.296 107.453 0.364
201907 -0.036 108.243 -0.044
201910 -0.316 107.927 -0.387
202001 -0.315 108.085 -0.385
202006 -0.117 108.401 -0.143
202009 -0.130 108.164 -0.159
202012 -0.254 108.559 -0.309
202103 -0.588 110.298 -0.705
202106 0.120 111.720 0.142
202109 -0.298 112.905 -0.349
202112 0.000 113.774 0.000
202203 -0.149 117.646 -0.168
202206 -0.331 120.806 -0.362
202209 -0.354 120.648 -0.388
202212 0.000 120.964 0.000
202303 -0.053 122.702 -0.057
202306 -0.194 124.203 -0.207
202309 -0.122 125.230 -0.129
202312 -0.486 125.072 -0.514
202403 -0.442 126.258 -0.463
202406 -0.037 127.522 -0.038
202409 -0.144 127.285 -0.150
202412 -0.162 127.364 -0.168
202503 -0.120 129.181 -0.123
202506 -0.208 129.892 -0.212
202509 -0.119 130.287 -0.121
202512 -0.077 130.366 -0.078
202603 -0.095 132.262 -0.095

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-1.12 mean?
BioHarvest Sciences (FRA:8MV0) has a E10 of €-1.12 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioHarvest Sciences and its competitors.
Is BioHarvest Sciences' E10 too high?
BioHarvest Sciences' current E10 is €-1.12. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' E10 compare to BRID and BOF?
BioHarvest Sciences' E10 of €-1.12 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Consumer Packaged Goods company?
A good E10 depends on the Consumer Packaged Goods industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioHarvest Sciences and its competitors. BioHarvest Sciences's current E10 is €-1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (FRA:8MV0) is currently considered Possible Value Trap. The stock's GF Value™ is €6.88, compared to a current price of €2.20 — trading 68% below its estimated fair value. The current E10 is €-1.12. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For BioHarvest Sciences (FRA:8MV0), the current E10 is €-1.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioHarvest Sciences (FRA:8MV0) Overvalued in 2026?

Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued. The current stock price of €2.20 is trading 68% below its estimated GF Value™ of €6.88. GuruFocus considers BioHarvest Sciences to be Possible Value Trap.

Key valuation signals for FRA:8MV0:

  • E10: €-1.12
  • GF Value™: €6.88 vs. price of €2.20 (68% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the FRA:8MV0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioHarvest Sciences Business Description

Other Exchanges BHST:USA
Address 1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score

Get the complete analysis for FRA:8MV0

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.20
Price
€6.88
GF Value